Mumbai: Sun Pharmaceutical Industries has got nod from USFDA to promote the generic version of Novartis’s Exelon capsules ‘Rivastigmine Tartrate.’
Rivastigmine Tartrate is used for the treatment of Alzheimer’s and Parkinson’s disease.
Sun gets FDA authorization for 1.5mg, 3mg, 4.5mg and 6mg drug potencies.
The yearly sales of Exelon capsules in the US market would be around $200 million in these strengths.
Kolkata: ITC Ltd, Indian market leader has entered into an agreement with Nagal
Mumbai: Putting an end to conjectures, Reliance Power Limited has made declaration that that its plan
Indiabulls Financial Services Limited has informed the Exchange that the Company’s Boar
Vishal Retail Ltd has declared that the company has opened four new Showrooms at different localities
Mumbai: Sun Pharmaceutical Industries has got nod from USFDA to promote the generic version of Novartis’s Exelon capsules ‘Rivastigmine Tartrate.’
Kolkata: ITC Ltd, Indian market leader has entered into an agreement with Nagal
Mumbai: Putting an end to conjectures, Reliance Power Limited has made declaration that that its plan
Indiabulls Financial Services Limited has informed the Exchange that the Company’s Boar
Vishal Retail Ltd has declared that the company has opened four new Showrooms at different localities
